Results 141 to 150 of about 457,033 (338)

Programmable Antigen‐Specific Immunity via Self‐Adjuvanting Nanovaccines Co‐Delivering Immune Modulators

open access: yesAngewandte Chemie, EarlyView.
The self‐adjuvanting vaccine—comprising a covalent conjugate of antigen and adjuvant—was formulated into cationic lipid nanoparticles smaller than 100 nm to facilitate uptake by immune cells, with supplemental adjuvants incorporated to modulate immune responses.
Keita Ito   +9 more
wiley   +2 more sources

Probing the Intergalactic Medium with Ly$\mathrm{\alpha}$ and 21 cm Fluctuations

open access: yes, 2017
We study 21cm and Ly$\mathrm{\alpha}$ fluctuations, as well as H$\mathrm{\alpha}$, while distinguishing between Ly$\mathrm{\alpha}$ emission of galactic, diffuse, and scattered intergalactic medium (IGM) origin.
Cooray, Asantha   +2 more
core   +1 more source

Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases

open access: yesAdvanced Science, EarlyView.
This review highlights a paradigm shift in which advanced immune cell therapies, initially developed for cancer, are now being harnessed to combat aging. By engineering immune cells to selectively clear senescent cells and remodel pro‐inflammatory tissue microenvironments, these strategies offer a novel and powerful approach to delay age‐related ...
Jianhua Guo   +5 more
wiley   +1 more source

Multimeric antibodies from antigen-specific human IgM+ memory B cells restrict Plasmodium parasites

open access: hybrid, 2021
Christopher D. Thouvenel   +18 more
openalex   +1 more source

A Prussian Blue Nanozyme‐Adjuvanted Vaccine Presenting Phosphocholine Antigens for Induction of Immunotolerance in Inflammatory Bowel Disease

open access: yesAdvanced Science, EarlyView.
ABSTRACT Inflammatory bowel disease (IBD) is a complex disorder characterized by chronic intestinal inflammation and impaired barrier function, for which effective long‐term therapies remain elusive. To address this challenge, we developed a novel nano‐vaccine that combines Prussian blue nanozymes (PBNZs) adjuvants with a ferritin carrier loaded with ...
Jingyi Sheng   +6 more
wiley   +1 more source

Study of Serum IgM, IgG, IL-37 Levels and IL-37 Gene Polymorphism in Women Infected with Trichomonas Vaginalis in Baqubah City

open access: yesProceedings of the International Conference on Applied Innovations in IT
Trichomoniasis is the most prevalent non-viral sexually transmitted infection globally, relying on both innate and adaptive immunity to combat the extracellular pathogen Trichomonas vaginalis. This study included 45 infected women and 45 healthy controls
Noor Ghassan   +2 more
doaj   +1 more source

Age-Related Decline in Natural IgM Function: Diversification and Selection of the B-1a Cell Pool with Age [PDF]

open access: bronze, 2016
Nichol E. Holodick   +3 more
openalex   +1 more source

AI‐Assisted Bioelectronics for Personalized Health Management

open access: yesAdvanced Electronic Materials, EarlyView.
Recent advances in artificial intelligence (AI)‐assisted bioelectronics, including materials, device fabrication, working mechanisms, AI‐hardware integration, and proof‐of‐concept applications in digital health management, are summarized. The emergence of AI‐assisted bioelectronic systems and potential solutions to existing challenges are discussed ...
Huiwen Xiong   +6 more
wiley   +1 more source

DESCRIPTION OF CUSTOM THREAD IGM TECHNIQUE WITH USE OF PDO FACIAL SUPPORT THREADS IN THE OROFACIAL HARMONIZATION.

open access: diamond, 2021
Gustavo Otoboni Molina   +3 more
openalex   +1 more source

Nance‐Horan Syndrome: Further Delineation of the Affected Male and the Female Carrier Phenotypes

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Nance‐Horan syndrome (NHS; OMIM 302350) is a rare, X‐linked syndrome characterized by bilateral congenital cataracts leading to profound vision loss, specific dental anomalies including characteristic screwdriver blade‐shaped incisors, facial anomalies, and intellectual disability.
Maria K. Haanpää   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy